Tech entrepreneur Bryan Johnson employs a different method called Project Blueprint to try to reverse aging, which means slowing the circadian clock, if not making the clock run withershins or counter-clockwise, The Hustle reported.
Photo Insert: Blueprint will cost Johnson $2 million in 2023, but the expectation is that science-based de-aging procedures will be more affordable in the future.
Bryan Johnson is taking the lead in this quest after he sold his payment processor Braintree Payment Solutions LLC for $800 million in 2013 and today serves as a de-aging guinea pig with a team of 30 experts.
His routine includes: Over 20 supplements and medicines; daily exercise and a strict sleep schedule, and; a 1,977-calorie vegan diet. He also undergoes numerous medical procedures, plus tests to measure his progress.
Regenerative medicine physician and team lead Oliver Zolman told Bloomberg that results aren’t “remarkable,” but their “small, reasonable results” may prove it’s genetically possible to reduce the medical age of our organs.
Blueprint will cost Johnson $2 million in 2023, but the expectation is that science-based de-aging procedures will be more affordable in the future.
It seems weird but so does everything in the longevity sector, which raised more than $40 billion in investments in 2021 and could become a $600-billion market by 2025, per TechCrunch.
Yet, Johnson is not alone. Altos Labs, a biotech company that launched with $3 billion in funding explores resetting the epigenome (which tells DNA to turn genes on or off).
Unity Biotechnology is developing a drug to clear senescent cells (cells that stop dividing but don’t die). Loyal, a startup that wants to extend your dog’s life. Even Google parent Alphabet has a longevity startup, called Calico, but no one seems to know what it does.